Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,400.96
(
-0.16%
)
US TECH 100
28,196.00
(
-1.18%
)
Dow Jones
49,760.56
(
0.11%
)
Brent Oil
104.44
(
-1.25%
)
Bitcoin
81,046.55
(
0.69%
)
News Focus
News Focus

Replies to post #241843 on Biotech Values

Replies to #241843 on Biotech Values
icon url

DewDiligence

03/31/22 10:00 AM

#241845 RE: randychub #241843

It looks almost everyone with ovarian cancer should get a PARP inhibitor. In fact, it's looked that way for quite a while, but some oncologists are still resistant to the idea.